Slide background

Glycomantra

A Biotechnology Firm

Leading The Translational Glycobiology Research

Slide background

Slide background

Slide background
Slide background

Startup biotechnology firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer and infectious disease

Our Products

We have developed natural high affinity galectin-3 inhibitors (patent pending)┬áthat may be used to treat cancers and fibrotic diseases. Click here to learn more…

Our Research

Current focus of our research is on the galectin-3, a member of the beta-galactoside-binding lectin family. Click here to learn more…

Our Services

Our experienced and dedicated team is ready to provide wide range of research services from simple one step protein or antibody purification…Click here to learn more…

Who We Are/Our Interest

We are a start up biotechnology firm leading the translational glycobiology research and interested in the development of carbohydrate-based therapeutics of cancer and infectious disease. Animal cell surfaces are covered with carbohydrates and proteins. These components mediate interactions between two cells or between the cell and the extra-cellular matrix components. These protein-carbohydrate interactions mediate various biological processes such as cell activation, growth regulation, apoptosis, and cancer metastasis. Infection of cells with bacteria or viruses is also mediated through protein-carbohydrate interactions.